A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma

Overview of attention for article published in Journal of Hematology & Oncology, October 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 1 news outlet
twitter: 25 X users

patent: 1 patent

Citations

dimensions_citation: 104 Dimensions

Readers on

mendeley: 116 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

MULTI-TARGET CHIMERIC ANTIGEN RECEPTOR COMPRISING CD38 TARGETING

Application WO-2024051057-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.